TC
NUVA

Trilogy Capital’s NuVasive, Inc. NUVA Stock Holding History

Trilogy Capital’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed -$4K – 605
2018
Q3 		$4K Hold
50
– – ﹤0.01% 440
2018
Q2 		$3K Hold
50
– – ﹤0.01% 435
2018
Q1 		$3K Buy
+50
New +$2.54K ﹤0.01% 368

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Trilogy Capital's NUVA Position: Q4 2018 in Review

Trilogy Capital sold out of NuVasive, Inc. (NUVA) in Q4 2018, closing a stake of 50 shares — an estimated $4K sold.

Trilogy Capital first reported a position in NUVA in Q1 2018 and held it in 3 quarters. The position peaked at $4K in Q3 2018. 290 funds tracked by Wall St. Rank hold NUVA as of Q4 2018.

  • Trilogy Capital reported no remaining NuVasive, Inc. position as of Q4 2018 after selling out during the quarter.
  • Trilogy Capital sold 50 NuVasive, Inc. shares in Q4 2018, an estimated $4K.
  • Trilogy Capital first reported a position in NuVasive, Inc. in Q1 2018 and held it in 3 quarters.
  • Trilogy Capital's NuVasive, Inc. position peaked at $4K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.